SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-044455
Filing Date
2021-08-16
Accepted
2021-08-16 08:06:01
Documents
5
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ovid-8k_20210816.htm 8-K 29161
2 EX-99.1 ovid-ex991_6.htm EX-99.1 58516
3 GRAPHIC g45hemfh5jha000003.jpg GRAPHIC 974727
4 GRAPHIC g45hemfh5jha000001.jpg GRAPHIC 17297
5 GRAPHIC g45hemfh5jha000002.jpg GRAPHIC 688
  Complete submission text file 0001564590-21-044455.txt   1456421
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 211174626
SIC: 2834 Pharmaceutical Preparations